Grade My Investments
Home › Free Stock Grades › NEOG

Neogen Corporation (NEOG) Stock Grade

NEOG · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$3.0B
P/E Ratio
—
Revenue Growth (YoY)
-2.7%
Net Margin
-0.9%
Return on Equity
—
Dividend Yield
None

About Neogen Corporation's fundamentals

Neogen Corporation is a healthcare device company with a $3.0 billion market capitalization that reported a net loss in its latest annual statement, reflecting a negative net margin of -0.9%. Revenue declined 2.7% year-over-year, indicating the company faced headwinds in its top-line growth during the period. Despite the accounting losses, the company generated positive free cash flow, suggesting that underlying cash generation from operations exceeded capital expenditure requirements. The company does not pay a dividend and lacks meaningful profitability metrics at this time.

Track NEOG free — no credit card required. Live grade + monthly AI report →